Hjem › Myelodysplastiske syndromer › Utah › Salt Lake City
Kliniske studier for Myelodysplastiske syndromer i Salt Lake City, UT
8 studier for Myelodysplastiske syndromer søker deltakere på steder i og rundt Salt Lake City (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RekruttererFase 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
- George E Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
RekruttererFase 3
- Huntsman Cancer Institute, Salt Lake City
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekruttererFase 1/2
- Primary Children's Hospital, Salt Lake City
Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)
RekruttererFase 1/2
- Intermountain Healthcare, Salt Lake City
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Rekrutterer
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
RekruttererFase 1/2
- Huntsman Cancer Institute, Salt Lake City
- Intermountain Healthcare, Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Salt Lake City
Myelodysplastiske syndromer-studier i andre byer
- Houston, TX43 studier
- Baldwin Park, CA26 studier
- New York City, NY21 studier
- Seattle, WA21 studier
- Washington, DC20 studier
- Tampa, FL19 studier
- Boston, MA19 studier
- Miami, FL17 studier
- Durham, NC14 studier
- Columbus, OH14 studier
- St. Louis, MO13 studier
- Atlanta, GA13 studier
Andre studier i Salt Lake City
- Ikke-småcellet lungekreft31 studier
- Kreft (alle typer)27 studier
- Brystkreft27 studier
- Kolorektal kreft22 studier
- Lungekreft21 studier
- Melanom21 studier
- Multipelt myelom21 studier
- Metastatisk kreft20 studier
- Eggstokkreft19 studier
- Fedme18 studier
- Akut myelogen leukemi17 studier
- Hjertesvikt17 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.